High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.

Autoria(s): O'Sullivan, Joe; Norman, A.R.; McCready, V.R.; Flux, G.; Cook, G.; Johnson, B.; Treleaven, J.; Dearnaley, D.P.
Data(s)

2004
Identificador

http://pure.qub.ac.uk/portal/en/publications/high-activity-rhenium186-hydroxyethylidene-diphosphonate-hedp-with-autologous-peripheral-blood-stem-cell-pbsc-transplant-a-novel-treatment-strategy-in-hormone-refractory-prostate-cancer-metastatic-to-bone(d6299819-19b8-4254-9bd1-cc929cddeb6b).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

O'Sullivan , J , Norman , A R , McCready , V R , Flux , G , Cook , G , Johnson , B , Treleaven , J & Dearnaley , D P 2004 , ' High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone. ' Journal of Clinical Oncology , vol 22 , pp. 397S-397S .
Tipo

article
Acesso ao item digital